VEEVBy Calypso Research5 min read

Veeva Systems (VEEV) Q3 2025 Earnings Analysis

CRM Overhaul Leaves Veeva's Revenue in the Rx for Recovery

Key Takeaways

Veeva Systems (VEEV) reported Q3 2025 earnings with revenue of $811M, representing a +16.0% year-over-year change. The stock moved -9.8% on earnings day.

The bull case: AI innovation and diversified product growth position Veeva for long-term leadership in life sciences cloud solutions.

The bear case: Customer attrition in CRM and competitive pressures from Salesforce may limit near-term growth and margins.

Financial Highlights

  • Revenue: $811M (+16.0% YoY)
  • Gross Profit: $612M (75.4% margin, +0.4% YoY)
  • Operating Income: $241M (29.7% margin, +3.8% YoY)
  • Net Income: $236M
  • TTM Revenue: $3.1B

Stock Performance

  • Earnings Day Move: -9.8%
  • Year-to-Date: -21.6%
  • 1-Year Return: -23.9%
  • vs. S&P 500 (since earnings): -8.1%
  • vs. Nasdaq (since earnings): -9.4%

View live VEEV data, AI chat, and interactive debates on Calypso →

What Management Said

Here are the key debates and direct quotes from Veeva Systems's Q3 2025 earnings call:

Transition of Top 20 Pharma Customers to Vault CRM vs. Salesforce

Sentiment: Positive

"CRM is about 20% of total revenue today, down from about 25% two years ago... Longer term, we don't expect any impact on our 2030 goals." — Brian Van Wagener
"We used to have 18 out of the top 20. Now we're maybe gonna have 14 or so. And now it's back to business as usual... But with a difference. Now we are entering the age of AI." — Peter Gassner

AI-Driven Innovation and Monetization Across Product Lines

Sentiment: Positive

"AI can dramatically increase the efficiency of safety case processing for adverse events—very specific, very impactful solutions." — Peter Gassner
"We will have agents in virtually every application area as we get through 2026." — Paul Shawah

Expansion of Crossix and Digital Transformation in Commercial

Sentiment: Positive

"Digital overall... is going up. Both in consumer and in HCP marketing because there are better digital avenues to reach people." — Paul Shawah
"Crossix continues to perform well... We expect it to be a nice growth driver over the next several years." — Brian Van Wagener

Long-Term Development Cloud Opportunities in R&D

Sentiment: Positive

"Development Cloud still has a lot of opportunities... RTSM, ECOA, and safety are areas where we see greenfield opportunities." — Peter Gassner
"Quality in manufacturing is becoming more critical, and our three main quality products work together in a way no other vendor offers." — Peter Gassner

Impact of AI on Sales Force Efficiency and Commercial Models

Sentiment: Positive

"We have seen some reductions in sales forces, but this is not AI-related. The industry is cautious about making significant changes." — Paul Shawah
"AI will redefine what a CRM system can do by driving insight generation and market advantage." — Peter Gassner

Bull Case

AI innovation and diversified product growth position Veeva for long-term leadership in life sciences cloud solutions.

Bear Case

Customer attrition in CRM and competitive pressures from Salesforce may limit near-term growth and margins.

Looking Ahead

With revenue growing +16.0% year-over-year, the key question is whether Veeva Systems can sustain this growth trajectory, particularly around transition of Top 20 Pharma Customers to Vault CRM vs. Salesforce. With operating margins at 29.7%, margin trends will remain a focal point. The market's negative earnings-day reaction signals that investors need to see stronger execution, and the next earnings report will be a key catalyst for the stock.

Frequently Asked Questions

What was Veeva Systems's revenue in Q3 2025?

Veeva Systems reported Q3 2025 revenue of $811M, representing a +16.0% year-over-year change.

Did Veeva Systems beat earnings expectations in Q3 2025?

The stock declined -9.8% on earnings day, suggesting the results fell short of market expectations. The current bull case centers on: AI innovation and diversified product growth position Veeva for long-term leadership in life sciences cloud solutions.

What is the bull case for VEEV stock?

The bull case for VEEV centers on: AI innovation and diversified product growth position Veeva for long-term leadership in life sciences cloud solutions.

What is the bear case for VEEV stock?

The bear case for VEEV centers on: Customer attrition in CRM and competitive pressures from Salesforce may limit near-term growth and margins.

How has VEEV stock performed since its Q3 2025 earnings?

VEEV moved -9.8% on the day of its Q3 2025 earnings report, underperforming the S&P 500 by +8.1% since earnings. Year-to-date, the stock has returned -21.6%.

Browse all 400+ earnings reports →

Learn More

Analyze VEEV in Real Time

This is a static snapshot. For live financial data, AI-powered chat, and interactive earnings debates for Veeva Systems and 400+ other stocks, explore the full platform.

Open VEEV on Calypso →

Calypso is an AI-powered equity research platform used by investment teams to cut earnings research time by over 80%.